|
Grant Dorsey, M.D., Ph.D.
Associate Professor in Residence
gdorsey@medsfgh.ucsf.edu
Mailing Address:
University of California, San Francisco
Division of Infectious Diseases
Box 0811
1001 Potrero Avenue, SFGH 30 408
San Francisco, CA 94143-0811
Office Location:
San Francisco General Hospital, Bldg. 30, Rm. 408
Research Interests:
Clinical and molecular studies of antimalarial drug resistance and the epidemiology of malaria; Interactions between HIV and malaria
Select Publications:
Dorsey G, Njama D, Kamya MR, Staedke SG, Gasasira A, Rosenthal PJ. 2002. Sulfadoxine/pyrimethamine alone or in combination with amodiaquine or artesunate for treatment of uncomplicated malaria: a longitudinal randomized trial. Lancet 360:2031-2038.
Dorsey G, Vlahos J, Kamya MR, Staedke SG, Rosenthal PJ. 2003. Prevention of increasing rates of treatment failure by combining sulfadoxine-pyrimethamine with artesunate or amodiaquine for the sequential treatment of malaria. Journal of Infectious Diseases. 188(8):1231-1238.
Nsobya SL, Parikh S, KirondeF, LubegaG, KamyaMR, Rosenthal PJ, Dorsey G. 2004. Molecular evaluation of the natural history of asymptomatic parasitemia in Ugandan children. Journal of Infectious Diseases. 189(12):220-6.
Dorsey G, Gasasira AF, Machekano R, Kamya MR, Staedke SG, Hubbard A. 2004. The impact of age, temperature, and parasite density on treatment outcomes from antimalarial clinical trials in Kampala, Uganda. American Journal of Tropical Medicine and Hygiene. 71(5):531-6.
Dorsey G, Dokomajilar C, Kiggundu M, Staedke SG, Kamya MR, Rosenthal PJ. 2004. Dihydrofolate reductase and dihydropteroate synthase genotypes and clinical response to sulfadoxine-pyrimethamine therapy alone and in combination. American Journal of Tropical Medicine and Hygiene. 71(6):758-63.
Education and Training:
M.D., Southwestern Medical Center, University of Texas, Dallas
Ph.D., Epidemiology, University of California, Berkeley
Residency, University of California, San Francisco
Fellowship, University of California, San Francisco
|
